Following False-Positive Results, Patients More Likely to Have Future Cancer Screenings

Share this content:
Prior experience with cancer screenings may factor into a patient's willingness to undergo future screening.
Prior experience with cancer screenings may factor into a patient's willingness to undergo future screening.

(HealthDay News) -- Patients who previously had a false-positive breast or prostate cancer screening test result are more likely to have future screenings, according to a study published online April 23 in Cancer.

Glen B. Taksler, Ph.D., from the Cleveland Clinic, and colleagues assessed whether 92,405 individuals aged 50 to 75 years (2006 to 2015) were up-to-date with their breast, prostate, or colorectal cancer screening. Differences in current status were assessed by whether patients had a previous false-positive test result.

The researchers found that women were more likely to be up-to-date with breast cancer screening if they previously had false-positive mammography results both without breast biopsy (adjusted odds ratio [aOR], 1.43) and with breast biopsy (aOR, 2.02; both P < 0.001). These same women were also more likely to be current for colorectal cancer screening (aOR range, 1.25 to 1.47, depending on breast biopsy; both P < 0.001). Similarly, men who previously had false-positive prostate cancer test results were more likely to be current with colorectal cancer screening (aOR without prostate imaging/biopsy, 1.22 [P = 0.039] and aOR with imaging/biopsy, 1.60 [P = 0.028]).

"Prior experience with cancer screenings may influence a patient's willingness to continue future screening," the authors write.

Abstract/Full Text (subscription or payment may be required)

You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters



Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs